Sulfated glycosaminoglycans in protein ...
Document type :
Article dans une revue scientifique
PMID :
Permalink :
Title :
Sulfated glycosaminoglycans in protein aggregation diseases
Author(s) :
Journal title :
Glycoconjugate journal
Abbreviated title :
Glycoconj. J.
Volume number :
34
Pages :
453-466
Publication date :
2017
ISSN :
1573-4986
English keyword(s) :
Heparan sulfate
Protein Aggregates
Protein aggregation disease
Animals
Glycosaminoglycans
Disease
Humans
Cell Communication
Amyloidosis
Sulfates
Protein Aggregation, Pathological
Protein Aggregates
Protein aggregation disease
Animals
Glycosaminoglycans
Disease
Humans
Cell Communication
Amyloidosis
Sulfates
Protein Aggregation, Pathological
HAL domain(s) :
Chimie/Chimie théorique et/ou physique
English abstract : [en]
Protein aggregation diseases are characterized by intracellular or extracellular deposition of misfolded and aggregated proteins. These aggregated deposits contain multiple proteinaceous and non-protein components that are ...
Show more >Protein aggregation diseases are characterized by intracellular or extracellular deposition of misfolded and aggregated proteins. These aggregated deposits contain multiple proteinaceous and non-protein components that are thought to play critical roles in the etiology and pathogenesis of protein aggregation diseases in vivo. One of these components, the sulfated glycosaminoglycans (GAGs), includes heparan sulfate, chondroitin sulfate, and keratan sulfate. The sulfated GAGs are negatively charged heteropolysaccharides expressed in all mammalian tissues. Enzymatically generated structural patterns and the degree of sulfation in GAGs determine GAGs' specific interactions with their protein ligands. Here, we review the potential roles of the sulfated GAGs in the pathogenesis and progression of protein aggregation diseases from a perspective of their sulfation modification. We also discuss the possibility of sulfated GAGs as therapeutic targets for protein aggregation diseases.Show less >
Show more >Protein aggregation diseases are characterized by intracellular or extracellular deposition of misfolded and aggregated proteins. These aggregated deposits contain multiple proteinaceous and non-protein components that are thought to play critical roles in the etiology and pathogenesis of protein aggregation diseases in vivo. One of these components, the sulfated glycosaminoglycans (GAGs), includes heparan sulfate, chondroitin sulfate, and keratan sulfate. The sulfated GAGs are negatively charged heteropolysaccharides expressed in all mammalian tissues. Enzymatically generated structural patterns and the degree of sulfation in GAGs determine GAGs' specific interactions with their protein ligands. Here, we review the potential roles of the sulfated GAGs in the pathogenesis and progression of protein aggregation diseases from a perspective of their sulfation modification. We also discuss the possibility of sulfated GAGs as therapeutic targets for protein aggregation diseases.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
CNRS
Université de Lille
Université de Lille
Collections :
Submission date :
2020-02-12T15:11:32Z
2021-07-13T09:05:35Z
2021-07-13T09:05:35Z